The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...

FDA Commissioner Marty Makary was met with a skeptical set of Senate appropriators Thursday when he testified on his agency’s ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar ...

Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

Covid vaccines from Pfizer and Moderna must carry expanded warning labels informing patients of the risk of rare heart inflammation. The FDA is also cracking down on off-brand GLP-1 drugs. Other ...

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...